Skip to main content
OpenTrials
Completed

NCT Number: NCT05326321

Effect of Virtual Reality Glasses in The Arteriovenous Fistule Cannulation Processon Paın and Patient Satisfaction

This research was conducted as a randomized controlled experimental study aiming to determine the impact of virtual reality glasses used in the AVF process on the pain felt by patients and patient satisfaction.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Chronic kidney disease (CKD) is a progressive, irreversible renal disease in which the ability of the body to maintain the balance of metabolism, fluid and electrolytes fails. Chronic kidney disease (CKD) is one of the major health problems with an increasing prevalence in the World. Hemodialysis as one of the most common methods of renal replacement therapy is a stressful procedure despite to maintain the survival of patients with chronic kidney disease that permanent and safe vascular access is one of the requirements of a successful hemodialysis. The pain of AVF puncture is common among the patients undergoing HD as acute and chronic pain which reported in more than 82% and 92% of them, respectively. Experience of the arteriovenous fistula puncture-related pain can have unpleasant effects on the patients, it causes that hemodialysis patients experience more disability, depression, irritability, and insomnia than other patients in adapting to stress. Experiencing continued pain can also affect the level of hemodialysis acceptance in patients and ultimately decrease quality of life. Therefore, pain control is an important priority in these patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Receiving HD treatment
  • Open to communication
  • Fully oriented
  • Without vision, hearing and perception problems
  • Without any psychiatric illness
  • Without a history of seizures such as epilepsy
  • HD treatment administered via AVF
  • İn the last day, no injection was made into any artery or vein from the place where the intervention will be performed
  • Without any signs of infection such as redness, swelling, open wound in the area where the intervention will be performed
  • Standardized Mini Mental Test value is 24 points and above
  • One-time needle attempt from AV

Exclusion criteria

  • Refusing to participate in the study
  • under the age of 18
  • Can't speak Turkish
  • Closed to communication and not fully oriented
  • Visual, hearing and perception problems
  • Any psychiatric illness
  • Having a history of seizures such as epilepsy
  • HD treatment not administered via AVF
  • Injection into any artery or vein from the place where the intervention will be performed in the last day,
  • Any signs of infection such as redness, swelling, open wound in the area to be operated
  • Using any pain medication before the procedure on the same day
  • SMMT value below 24 in patients over 65 years of age
  • Cannulation procedure not performed with a 16 G AVF needle
  • Patients with multiple injections from the AVF

Treatment and study plan

Study Group

Other

The patients in the intervention group were shown a video with virtual reality glasses for an average of 5 minutes, 2 minutes before the start of the AVF cannulation procedure and 3 minutes throughout the procedure.

Primary outcomes

  1. Pain evaluated using the Visual Analog Scale

    Time frame: Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses)

    The patient marks a value between 1 and 10 on the Visual Analog Scale (VAS). As the value increases, the severity of pain increases.

Secondary outcomes

  1. Blood pressure

    Time frame: Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses)

    systolic blood pressure (SBP), diastolic blood pressure (DBP), mmHg

  2. Heart rate

    Time frame: Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses)

    beats per minute

  3. respiratory rate

    Time frame: Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses)

    ekspiration and inspiration per minute

  4. peripheral oxygen saturation

    Time frame: Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses)

    %, percentage of oxygenated hemoglobin in peripheral arterial blood

Sponsors and collaborators

Lead sponsor

Mersin University

Other

Registry information

Official study title

Effect of Virtual Reality Headset Glasses Used in The Arteriovenous Fistule Cannulation Processon Paın and Patient Satisfaction

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Apr 13, 2022
Registry last updated
Apr 13, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.